Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.615 USD | -4.44% | -13.71% | -45.59% |
05-09 | BioXcel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-09 | Transcript : BioXcel Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.59% | 63.43M | |
+16.93% | 121B | |
+13.33% | 107B | |
-5.90% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.45% | 15.31B | |
+3.02% | 14.08B | |
+23.65% | 11.74B |
- Stock Market
- Equities
- BTAI Stock
- News BioXcel Therapeutics, Inc.
- Guggenheim Adjusts Price Target on BioXcel Therapeutics to $46 From $50, Maintains Buy Rating